MABN794 Sigma-AldrichAnti-GLAST Antibody, clone 8C11.1
Anti-GLAST Antibody, clone 8C11.1 is an antibody against GLAST for use in Western Blotting, Immunohistochemistry .
More>> Anti-GLAST Antibody, clone 8C11.1 is an antibody against GLAST for use in Western Blotting, Immunohistochemistry . Less<<Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H, R | WB, IH(P) | M | Purified | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Purified |
Presentation | Purified mouse monoclonal IgG1λ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
Packaging Information | |
---|---|
Material Size | 100 μg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
MABN794 | 04055977166644 |
Documentation
Anti-GLAST Antibody, clone 8C11.1 Ficha datos de seguridad (MSDS)
Título |
---|
Anti-GLAST Antibody, clone 8C11.1 Certificados de análisis
Cargo | Número de lote |
---|---|
Anti-GLAST, clone 8C11.1 - 3167609 | 3167609 |
Anti-GLAST, clone 8C11.1 - 3250991 | 3250991 |
Anti-GLAST, clone 8C11.1 - 3389915 | 3389915 |
Anti-GLAST, clone 8C11.1 - 3866884 | 3866884 |
Anti-GLAST, clone 8C11.1 - 3944522 | 3944522 |
Anti-GLAST, clone 8C11.1 - 4163455 | 4163455 |
Anti-GLAST, clone 8C11.1 -2710635 | 2710635 |
Anti-GLAST, clone 8C11.1 -2764892 | 2764892 |
Anti-GLAST, clone 8C11.1 -2814887 | 2814887 |
Anti-GLAST, clone 8C11.1 -Q2569068 | Q2569068 |
Licencias necesarias e Información técnica
Cargo |
---|
White Paper: Further considerations of antibody validation and usage. |